GlassScriptPhysician profile
Mohamad Saad
NPI 1396934113
$2,645.55
in general payments reported to CMS, 2019-2025
28 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $334 · 2021: $250 · 2022: $179 · 2023: $453 · 2024: $889 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132 · Travel and Lodging: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.83 |
| Travel and Lodging | $430.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $607.73 | 2020-2024 | Da Vinci Surgical System |
| Baxter Healthcare | $378.53 | 2019-2021 | |
| Kerecis Limited | $329.65 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $155.94 | 2019-2024 | Collagenase Santyl |
| Medtronic, INC. | $154.97 | 2025 | Transorb |
| Sirtex Medical INC | $146.41 | 2023 | Sir-Spheres Microspheres |
| Aesculap, INC. | $120.48 | 2023 | Elan 4, Aesculap |
| Mimedx Group, INC. | $94.65 | 2024 | |
| Ethicon US, LLC | $86.37 | 2022-2024 | Echelon; Endopath, Ethicon, Vistaseal |
| Access Pro Medical, LLC | $80.89 | 2022-2023 | Matriderm |
| Polynovo North America LLC | $60.57 | 2022-2024 | Novosorb Btm |
| Shire North American Group INC | $47.19 | 2019 | |
| Integra Lifesciences Corporation | $46.23 | 2024-2025 | Integra, Surgimend, Omnigraft |
| Stryker Corporation | $39.63 | 2021 | |
| Davol INC. | $36.41 | 2021-2023 | Phasix Mesh |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $32.73 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.14 | 2020-2021 | |
| Angiodynamics, INC. | $24.19 | 2020 | |
| Convatec INC. | $22.61 | 2019 | |
| Acera Surgical, INC. | $21.27 | 2025 | Restrata Wound Matrix |
| Bard Access Systems, INC. | $20.91 | 2019 | |
| W. L. Gore & Associates, INC. | $20.48 | 2019 | |
| Kci USA, INC. | $19.07 | 2019 | |
| Teleflex LLC | $18.21 | 2025 | Deknatel |
| Musculoskeletal Transplant Foundation INC. | $14.57 | 2021 | |
| Acell, INC. | $13.55 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $13.22 | 2019 | |
| Bolder Surgical LLC | $10.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamad Saad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.